Treatment with ribociclib shows favourable immunomodulatory effects in patients with hormone receptor-positive breast cancer—findings from the RIBECCA trial

Diagnostic delay is more frequent in triple negative breast cancer than in hormone receptor-positive breast cancer

10.1055/s-0040-1710602 ◽

2020 ◽

Author(s):

S Baumgartner ◽

U Güth ◽

K Reeve ◽

C Elfgen

Keyword(s):

Breast Cancer ◽

Triple Negative Breast Cancer ◽

Hormone Receptor ◽

Triple Negative ◽

Diagnostic Delay ◽

Faculty Opinions recommendation of Adjuvant Endocrine Therapy for Women With Hormone Receptor-Positive Breast Cancer: ASCO Clinical Practice Guideline Focused Update.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.734467013.793556634 ◽

2019 ◽

Author(s):

Eva Chalas

Keyword(s):

Breast Cancer ◽

Clinical Practice ◽

Endocrine Therapy ◽

Clinical Practice Guideline ◽

Practice Guideline ◽

Hormone Receptor ◽

Adjuvant Endocrine Therapy ◽

HOXB7 siRNA delivered by hybrid nanoparticles and the co-therapy with tamoxifen: promising strategy against hormone receptor positive breast cancer

10.3390/iocn2020-07845 ◽

2020 ◽

Author(s):

Frederico Pittella ◽

Ana Beatriz Valle ◽

Ana Cristina Gualberto ◽

Kézia Ferreira ◽

Tânia Pasa ◽

...

Keyword(s):

Breast Cancer ◽

Hormone Receptor ◽

Hybrid Nanoparticles ◽

Promising Strategy ◽

7P An optimized Breast Cancer Index node-positive (BCIN+) prognostic model for late distant recurrence in patients with hormone receptor-positive (HR+) node-positive breast cancer

Annals of Oncology ◽

10.1016/j.annonc.2021.03.021 ◽

2021 ◽

Vol 32 ◽

pp. S23-S24

Author(s):

G-J. Liefers ◽

I. Noordhoek ◽

Y. Zhang ◽

D.C. Sgroi ◽

H. Putter ◽

...

Keyword(s):

Breast Cancer ◽

Hormone Receptor ◽

Prognostic Model ◽

Distant Recurrence ◽

Node Positive ◽

Breast Cancer Index ◽

Trends in endocrine therapy prescription and survival in patients with non-metastatic hormone receptor positive breast cancer treated with endocrine therapy: A population based-study

The Breast ◽

10.1016/j.breast.2021.06.003 ◽

2021 ◽

Author(s):

Ariane Mamguem Kamga ◽

Oumar Billa ◽

Sylvain Ladoire ◽

Marie-Laure Poillot ◽

Geneviève Jolimoy ◽

...

Keyword(s):

Breast Cancer ◽

Endocrine Therapy ◽

Hormone Receptor ◽

Population Based ◽

Population Based Study ◽

CDK 4/6 inhibitors and stereotactic radiation in the management of hormone receptor positive breast cancer brain metastases

Journal of Neuro-Oncology ◽

10.1007/s11060-019-03260-6 ◽

2019 ◽

Vol 144 (3) ◽

pp. 583-589 ◽

Cited By ~ 14

Author(s):

Nicholas B. Figura ◽

Thrisha K. Potluri ◽

Homan Mohammadi ◽

Daniel E. Oliver ◽

John A. Arrington ◽

...

Keyword(s):

Breast Cancer ◽

Brain Metastases ◽

Hormone Receptor ◽

Stereotactic Radiation ◽

Breast Cancer Brain Metastases ◽

Antitumor properties of Salvianolic acid B against triple-negative and hormone receptor-positive breast cancer cells via ceramide-mediated apoptosis

Oncotarget ◽

10.18632/oncotarget.26348 ◽

2018 ◽

Vol 9 (91) ◽

pp. 36331-36343 ◽

Cited By ~ 12

Author(s):

Wei Sha ◽

Yanfei Zhou ◽

Zhi-Qiang Ling ◽

Guiqin Xie ◽

Xiaowu Pang ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Cells ◽

Hormone Receptor ◽

Breast Cancer Cells ◽

Triple Negative ◽

Salvianolic Acid B ◽

Salvianolic Acid ◽

Antitumor Properties ◽

Use of luteinising-hormone-releasing hormone agonists as adjuvant treatment in premenopausal patients with hormone-receptor-positive breast cancer: a meta-analysis of individual patient data from randomised adjuvant trials

The Lancet ◽

10.1016/s0140-6736(07)60778-8 ◽

2007 ◽

Vol 369 (9574) ◽

pp. 1711-1723 ◽

Cited By ~ 255

Keyword(s):

Breast Cancer ◽

Adjuvant Treatment ◽

Hormone Receptor ◽

Luteinising Hormone ◽

Individual Patient Data ◽

Meta Analysis ◽

Releasing Hormone ◽

Premenopausal Patients ◽

Hormone Receptor-Positive Breast Cancer Has a Worse Prognosis in Male Than in Female Patients

Clinical Breast Cancer ◽

10.1016/j.clbc.2017.03.005 ◽

2017 ◽

Vol 17 (5) ◽

pp. 356-366 ◽

Cited By ~ 15

Author(s):

Xiaoxian Li ◽

Jing Yang ◽

Uma Krishnamurti ◽

Lei Huo ◽

Kevin C. Ward ◽

...

Keyword(s):

Breast Cancer ◽

Hormone Receptor ◽

Female Patients ◽

Worse Prognosis ◽

Impact of FOXA1 Expression on the Prognosis of Patients with Hormone Receptor-Positive Breast Cancer

Annals of Surgical Oncology ◽

10.1245/s10434-011-2094-4 ◽

2011 ◽

Vol 19 (4) ◽

pp. 1145-1152 ◽

Cited By ~ 35

Author(s):

Yuichi Hisamatsu ◽

Eriko Tokunaga ◽

Nami Yamashita ◽

Sayuri Akiyoshi ◽

Satoko Okada ◽

...

Keyword(s):

Breast Cancer ◽

Hormone Receptor ◽

Foxa1 Expression ◽